You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Recent awards include:
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at S&P Capital IQ Pro or S&P Capital IQ .
Biotechnology company Inscripta raises $125M in series D round
S&P Capital IQ Pro | Powering Your Edge
Street Talk Episode 81: Amid strong recovery, Banc of California hearing more M&A chatter
S&P Capital IQ Pro | Unrivaled Sector Coverage
Banking Essentials Newsletter: September Edition
Inscripta Inc. raised $125 million in its series D funding round, which was led by Paladin Capital Group.
New investors JS Capital Management LLC and Oak HC/FT Partners LLC participated in the round, alongside existing investors.
Inscripta has now raised a total of $259.5 million.
Inscripta is a Boulder, Colo.-based biotechnology company that is developing a benchtop platform for genome-scale engineering.